| scholarly article | Q13442814 |
| P50 | author | Xiao-Jie Yu | Q82377126 |
| Liqin Du | Q89842627 | ||
| P2093 | author name string | Gail E Tomlinson | |
| Alexander Pertsemlidis | |||
| Yidong Chen | |||
| Tzu-Hung Hsiao | |||
| Zhenze Zhao | |||
| Xiuye Ma | |||
| Adam Kosti | |||
| Uthra Suresh | |||
| Gregory Lin | |||
| P2860 | cites work | miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. | Q37340463 |
| The proto-oncogene KRAS is targeted by miR-200c | Q37649657 | ||
| MicroRNA function in cancer: oncogene or a tumor suppressor? | Q37655612 | ||
| Neuroblastoma: biology, prognosis, and treatment | Q37683919 | ||
| Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma | Q39243346 | ||
| HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma | Q39555632 | ||
| MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets | Q39820130 | ||
| High-content screening as a universal tool for fingerprinting of cytotoxicity of nanoparticles | Q39885387 | ||
| Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research | Q39908892 | ||
| Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence | Q39993069 | ||
| A simple, flexible, nonfluorescent system for the automated screening of neurite outgrowth | Q40338925 | ||
| Role of cyclic amp in differentiation of human neuroblastoma cells in culture | Q40341427 | ||
| MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1 | Q42123071 | ||
| Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening | Q42809108 | ||
| Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. | Q44328896 | ||
| Neuroblastoma | Q54265665 | ||
| Induction of neurite outgrowth in the IMR-32 human neuroblastoma cell line by nerve growth factor. | Q55490611 | ||
| Phenotypic changes of human neuroblastoma cells in culture induced by 12‐O‐tetradecanoyl‐phorbol‐13‐acetate | Q71005261 | ||
| miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 | ||
| The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing | Q24631683 | ||
| Widespread microRNA repression by Myc contributes to tumorigenesis | Q24647067 | ||
| Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
| Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study | Q24658339 | ||
| Combinatorial microRNA target predictions | Q27860510 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
| Characterization of microRNA expression profiles in normal human tissues | Q29615492 | ||
| Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution | Q29616370 | ||
| A quantitative method for analysis of in vitro neurite outgrowth | Q33287785 | ||
| Differentiation therapy of leukemia: 3 decades of development | Q33409795 | ||
| Automated microscopy for high-content RNAi screening | Q33533546 | ||
| Large-scale expression analysis reveals distinct microRNA profiles at different stages of human neurodevelopment | Q33608739 | ||
| MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma | Q33803485 | ||
| A rapid, inexpensive high throughput screen method for neurite outgrowth | Q33828248 | ||
| Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group | Q33876841 | ||
| microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma | Q33893064 | ||
| microRNA and cancer | Q33954625 | ||
| Differentiating agents in pediatric malignancies: retinoids in neuroblastoma. | Q34108090 | ||
| Neuroblastoma: biological insights into a clinical enigma | Q34180699 | ||
| A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2 | Q34357876 | ||
| miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. | Q34482630 | ||
| MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2 | Q35042737 | ||
| Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice | Q35086711 | ||
| Solid Tumor Differentiation Therapy - Is It Possible? | Q36071880 | ||
| The MYCN oncogene is a direct target of miR-34a | Q36926506 | ||
| MicroRNA reexpression as differentiation therapy in cancer | Q37286627 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell differentiation | Q210861 |
| microRNA | Q310899 | ||
| neuroblastoma | Q938205 | ||
| P304 | page(s) | 2499-2512 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation | |
| P478 | volume | 5 |
| Q40528981 | A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells |
| Q38747810 | Action of HMGB1 on miR-221/222 cluster in neuroblastoma cell lines |
| Q36307073 | Association between single nucleotide polymorphisms in MiR219-1 and MiR137 and susceptibility to schizophrenia in a Chinese population |
| Q91707651 | Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options |
| Q50003166 | Differential expression of microRNAs in the normal skin of the Han and Uyghur populations in Xinjiang Province |
| Q35096787 | Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling |
| Q89899063 | High-throughput fluorescence-based screen identifies the neuronal microRNA miR-124 as a positive regulator of alphavirus infection |
| Q38690311 | Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells |
| Q47304723 | Induction of morphological and functional differentiation of human neuroblastoma cells by miR-124. |
| Q28082679 | Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer |
| Q38531097 | Long noncoding RNAs and neuroblastoma |
| Q34718013 | MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer |
| Q35814865 | MicroRNA library screening identifies growth-suppressive microRNAs that regulate genes involved in cell cycle progression and apoptosis. |
| Q52640461 | MicroRNA-194 Regulates the Development and Differentiation of Sensory Patches and Statoacoustic Ganglion of Inner Ear by Fgf4. |
| Q92193233 | MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution |
| Q92015499 | Opportunities and challenges of circulating biomarkers in neuroblastoma |
| Q58766575 | Phenotypic miRNA Screen Identifies miR-26b to Promote the Growth and Survival of Endothelial Cells |
| Q89842629 | The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression |
| Q26740283 | The emerging role of miR-506 in cancer |
| Q90054054 | The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5 |
| Q31095310 | Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data |
| Q47121878 | Unveiling massive numbers of cancer-related urinary-microRNA candidates via nanowires |
| Q53695419 | miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer. |
| Q42329734 | miR-506 suppresses neuroblastoma metastasis by targeting ROCK1 |
| Q60302214 | microRNA-2110 functions as an onco-suppressor in neuroblastoma by directly targeting Tsukushi |
| Q38300511 | microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest. |
Search more.